Literature DB >> 3485094

von Willebrand factor binds specifically to sulfated glycolipids.

D D Roberts, S B Williams, H R Gralnick, V Ginsburg.   

Abstract

The human plasma glycoprotein Factor VIII/von Willebrand factor (vWF) binds specifically and with high affinity to sulfatides (galactosylceramide-I3-sulfate). vWF does not bind to gangliosides, neutral glycolipids, phospholipids, or cholesterol 3-sulfate. Although the largest oligomers of vWF bind preferentially to sulfatides, vWF monomers and dimers also bind but with reduced affinity. vWF binding is inhibited at high ionic strength or low pH, by some sulfated polysaccharides and by antibodies to vWF. Binding of vWF to sulfatides is probably responsible for its agglutination of aldehyde-fixed erythrocytes and may play a role in vWF-induced platelet adhesion or platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485094

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis.

Authors:  Takayuki Nakayama; Tadashi Matsushita; Koji Yamamoto; Noriko Mutsuga; Tetsuhito Kojima; Akira Katsumi; Norihiko Nakao; J Evan Sadler; Tomoki Naoe; Hidehiko Saito
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

2.  Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG.

Authors:  S M Gantt; P Clavijo; X Bai; J D Esko; P Sinnis
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

3.  Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.

Authors:  M Kyogashima; J Onaya; A Hara; T Taketomi
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

4.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

5.  Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.

Authors:  Lixuan Wang; Yuji Kamijo; Akihiro Matsumoto; Takero Nakajima; Makoto Higuchi; Reiji Kannagi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Glycoconj J       Date:  2011-04-19       Impact factor: 2.916

6.  Intervention in endotoxin shock by sulfatide (I3SO3-GalCer) with a concomitant reduction in tumor necrosis factor alpha production.

Authors:  H Higashi; Y Suzuki; N Mukaida; N Takahashi; D Miyamoto; K Matsushima
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

7.  Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

Authors:  Rui Hu; Gang Li; Yuji Kamijo; Toshifumi Aoyama; Takero Nakajima; Teruo Inoue; Koichi Node; Reiji Kannagi; Mamoru Kyogashima; Atsushi Hara
Journal:  Glycoconj J       Date:  2007-07-27       Impact factor: 2.916

Review 8.  Platelet adhesion under flow.

Authors:  Zaverio M Ruggeri
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

9.  Role of extracellular hemoglobin in thrombosis and vascular occlusion in patients with sickle cell anemia.

Authors:  Zhou Zhou; Molly Behymer; Prasenjit Guchhait
Journal:  Anemia       Date:  2010-12-27

10.  Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes.

Authors:  U Frevert; P Sinnis; C Cerami; W Shreffler; B Takacs; V Nussenzweig
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.